ALAN VALENZUELA: Open Payments
NPI 1598048407 · BANNING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 14 payments from 8 companies in 2025. Trend: 2023 $218 · 2024 $257 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $76 |
| Amgen Inc. | 2 | $50 |
| Exact Sciences Corporation | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Boston Scientific Corporation | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| SCILEX PHARMACEUTICALS INC. | 1 | $16 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
Products named: OTEZLA, Cologuard Collection Kit, Kerendia, Wegovy, WaveWriter Alpha Prime 16, ELIQUIS, ZTLido, ACCRUFER.
Industry payments across CA — which companies pay providers there.
